SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : DECODE GENETICS-*DCGN
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DewDiligence_on_SI who wrote (203)8/4/2005 8:12:52 PM
From: keokalani'nui  Read Replies (1) of 313
 
I agree with that. 2k N doesn't sound like enough for me. I was thinking more like 5-8k. They don't have an incidents-based P2 to work from so I sure hope the new guy argues for a much, much bigger P3 than 2k.

OTOH, maybe they have other FLAP-associated clinical risk factors to add to the enrollment criteria we don't know about.

I missed the significance of the FDA announcement. It just sounded like regulatory response procedure. You sumit, we respond within 60 days.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News